Cargando…

Removing anonymity protection and utilization review decisions: a real-world case under a single-payer health system

The effects of anonymity on utilization review has never been examined in the real world. This study aimed to evaluate the impact of removing anonymity protection for claims reviewers on their review decisions. Using a single-blinded repeated measures design, we randomly selected 1457 claims cases (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chih-Kuang, Chien, Shih-Jung, Lee, Po-Chang, Cheng, Shou-Hsia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288443/ https://www.ncbi.nlm.nih.gov/pubmed/35842541 http://dx.doi.org/10.1038/s41598-022-16536-1

Ejemplares similares

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
por: Roberts, Melissa H., et al.
Publicado: (2020)

Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021)

Using Certification to Promote Uptake of Real-World Evidence by Payers
por: Segal, Jodi B., et al.
Publicado: (2016)

Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians
por: Yang, Jingyan, et al.
Publicado: (2021)

Anonymous Real-Time Analytics Monitoring Solution for Decision Making Supported by Sentiment Analysis
por: de Oliveira Júnior, Gildásio Antonio, et al.
Publicado: (2020)

Utility-preserving anonymization for health data publishing
por: Lee, Hyukki, et al.
Publicado: (2017)

Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative
por: Edgar, Babette S, et al.
Publicado: (2021)

Payer perceptions on the use of economic models in oncology decision making
por: Biskupiak, Joseph, et al.
Publicado: (2021)

Utility-driven assessment of anonymized data via clustering
por: Ferrão, Maria Eugénia, et al.
Publicado: (2022)

Anonymous communication networks: protecting privacy on the web
por: Peng, Kun
Publicado: (2014)

Trends in Payer Type for Emergency Department Visits in California, 2011-2019
por: Hsia, Renee Y., et al.
Publicado: (2023)

Commentary on “Health Spending Under Single-Payer Approaches”
por: Ginsburg, Paul B.
Publicado: (2020)

Real-world analysis of insurance churn among young adults with schizophrenia using the Colorado All-Payer Claims Database
por: Pesa, Jacqueline, et al.
Publicado: (2022)

The anonymous venetian
por: Leon, Donna

Neurotics Not Anonymous
por: Quine, Michael
Publicado: (1968)

Neurotics Anonymous
por: Spinks, Marie
Publicado: (1967)

Anonymous Communications
Publicado: (1842)

Sincerely, Anonymous
por: Paterson, Grace
Publicado: (2020)

Hospitals and the Tax-Payer
Publicado: (1920)

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)

Should Insurers Pay the Same Fees Under an All-Payer System?
por: Kominski, Gerald F., et al.
Publicado: (1994)

The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers
por: Pratt, Nicole, et al.
Publicado: (2022)

Measuring the impact of anonymization on real-world consolidated health datasets engineered for secondary research use: Experiments in the context of MODELHealth project
por: Pitoglou, Stavros, et al.
Publicado: (2022)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Building an Anonymization Pipeline
por: Arbuckle, Luk
Publicado: (2020)

Anonymity for Young Criminals
Publicado: (1921)

Universalizing anonymity anxiety
por: Cahill, Courtney Megan
Publicado: (2016)

Port-Based Anonymous Communication Network: An Efficient and Secure Anonymous Communication Network
por: Meng, Xiance, et al.
Publicado: (2023)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

An All-Payer Risk Model for Super-Utilization in a Large Safety Net System
por: Ziring, Jeremy, et al.
Publicado: (2018)

Utilization of anonymization techniques to create an external control arm for clinical trial data
por: Mehtälä, Juha, et al.
Publicado: (2023)

Health Care Service Utilization among Patients with Bladder Pain Syndrome/Interstitial Cystitis in a Single Payer Healthcare System
por: Chung, Shiu-Dong, et al.
Publicado: (2014)

Using real-time, anonymous staff feedback to improve staff experience and engagement
por: Frampton, Anne, et al.
Publicado: (2017)

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

Contextual Anonymization for Secondary Use of Big Data in Biomedical Research: Proposal for an Anonymization Matrix
por: Rumbold, John, et al.
Publicado: (2018)

Lost in Anonymization — A Data Anonymization Reference Classification Merging Legal and Technical Considerations
por: Vokinger, Kerstin N., et al.
Publicado: (2020)

Preventing and Protecting Against Internet Research Fraud in Anonymous Web-Based Research: Protocol for the Development and Implementation of an Anonymous Web-Based Data Integrity Plan
por: Hohn, Kris L, et al.
Publicado: (2022)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b73b4abfm5hab44kujth1q1d6e